Trial Profile
A pilot study to evaluate topical bevacizumab for the treatement of neovascular glaucoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Dec 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Neovascular glaucoma
- Focus Therapeutic Use
- 04 Dec 2015 New trial record